These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Genomics stocks: profiting from biotech. Sherrid P US News World Rep; 2000 Jan; 128(4):57. PubMed ID: 11184126 [No Abstract] [Full Text] [Related]
12. The rise of venture capital and biotechnology in the US and Europe. Lee DP; Dibner MD Nat Biotechnol; 2005 Jun; 23(6):672-6. PubMed ID: 15940233 [No Abstract] [Full Text] [Related]
13. US venture capital for biotechnology. Dibner MD; Trull M; Howell M Nat Biotechnol; 2003 Jun; 21(6):613-7. PubMed ID: 12776144 [No Abstract] [Full Text] [Related]
14. Delisting threat looms large on biotech front. Lawrence S Nat Biotechnol; 2005 Jan; 23(1):5. PubMed ID: 15637598 [No Abstract] [Full Text] [Related]
15. Genomics companies boom on New York stock exchange. Smaglik P Nature; 2000 Jan; 403(6765):4. PubMed ID: 10651566 [No Abstract] [Full Text] [Related]
19. Biotechnology financing dilemmas and the role of special purpose entities. Schiff L; Murray F Nat Biotechnol; 2004 Mar; 22(3):271-7. PubMed ID: 14990945 [No Abstract] [Full Text] [Related]
20. When a long shot is worth a shot. Jacobs T; Fischer J Nat Biotechnol; 2005 Jul; 23(7):805. PubMed ID: 16003361 [No Abstract] [Full Text] [Related] [Next] [New Search]